IMMUNITYBIO, INC.

Profile

Company Names

IMMUNITYBIO, INC.
NANTKWEST, INC.
CONKWEST, INC.
ZELLERX CORP

Addresses

3530 JOHN HOPKINS COURT, SAN DIEGO, CA 92121

2533 SOUTH COAST HIGHWAY 101, SUITE 210, CARDIFF-BY-THE-SEA, CA 92007

15502 CHURCHHILL DOWNS, RANCHO SANTA FE, CA 92607

Phone Numbers

858-633-0300
(858) 633-0300
912 838 2257

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

ILLINOIS

Total Amount Raised:

$640,072,732.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2023-09-11 
$469,986,600.00 
$469,986,600.00 
$0.00 
Equity, Debt 
7
2022-07-09 
$10,656,035.00 
$10,656,035.00 
$0.00 
Equity 
6
2015-07-31 
$17,000,000.00 
$17,000,000.00 
$0.00 
Equity 
5
2015-06-10 
$78,004,041.00 
$78,004,041.00 
$0.00 
Equity 
4
2014-12-23 
$47,495,481.00 
$47,495,481.00 
$0.00 
Equity 
3
2014-12-16 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
2
2014-04-02 
$6,504,875.00 
$9,600,000.00 
$3,095,125.00 
Equity 
1
2009-09-30 
$425,700.00 
$500,000.00 
$74,300.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
 
ADCOCK 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
 
BLASZYK 
DIRECTOR
CHERYL 
 
COHEN 
DIRECTOR
RICHARD 
 
GOMBERG 
EXECUTIVE OFFICER
STEVEN 
 
GORLIN 
DIRECTOR
RONALD 
 
HERBERMAN 
DIRECTOR
HENRY 
 
JI, PH.D. 
DIRECTOR
HANS 
 
KLINGEMANN 
DIRECTOR
HANS 
G. 
KLINGEMANN 
DIRECTOR
HANS 
 
KLINGEMANN, M.D., PH.D. 
DIRECTOR
HANS 
 
KLINGERMANN 
DIRECTOR
RICHARD 
 
KUSSEROW 
DIRECTOR
LINDA 
 
MAXWELL 
DIRECTOR
JOHN 
 
POTTS 
DIRECTOR
JOHN 
T. 
POTTS, JR., M.D. 
DIRECTOR
CHRISTOBEL 
 
SELECKY 
DIRECTOR
BARRY 
 
SIMON 
EXECUTIVE OFFICER, DIRECTOR
BARRY 
SIMON 
EXECUTIVE OFFICER, DIRECTOR
BARRY 
J. 
SIMON, M.D. 
EXECUTIVE OFFICER, DIRECTOR
PATRICK 
 
SOON-SHIONG, M.D. 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
C. 
THOMAS, JR. 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-09-11 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2022-07-09 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-07-31 
D/A
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-06-10 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-06-10 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2014-12-23 
D
BIOTECHNOLOGY 
 
$5,000,001 - $25,000,000 
Equity 
2014-12-16 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2014-04-02 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2009-09-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
PALLADIUM CAPITAL ADVISORS, LLC
NONE
NONE
PALLADIUM CAPITAL ADVISORS, LLC
NONE
NONE
NONE
HEALTHPRO BIOVENTURES
NONE